Pralatrexate is a pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma. It is grouped under the following drug class(es): Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Folotyn, N-{4-[1-(2 and 4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid. Its PubChem CID is 148121.
Pralatrexate
| CAS No | 146464-95-1 |
|---|---|
| Molecular Formula | C23H23N7O5 |
| Molecular Weight | 477.5 g/mol |
| Synonyms | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pralatrexate is a pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma.
The listed CAS number is 146464-95-1.
The listed molecular formula is C23H23N7O5.
The listed molecular weight is 477.5 g/mol.
(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid.
The source lists Folotyn, N-{4-[1-(2 and 4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid.